This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated AOX1 Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-AOX1 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~147.9 kDa | |
| Gel | 8–10% (standard starting point) | |
| Positive control | Adrenal gland (IHC candidate; verify WB) +2 more | |
| Negative control | Adipose tissue (IHC candidate; verify WB) |
| PTM | Phosphorylated | |
| Caveat | Phosphorylation-state controls | |
| Gene-set association | MSigDB Hallmark membership | |
| Isoform | 1 isoform(s) |
The A02144-2 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | MCF-7, sp2/0, PC12 (catalog A02144-2) |
| Gel % | 8–10% (standard starting point) |
| Load | 20–30 µg total protein per lane; optimize for abundance (standard starting point) |
| Transfer | Wet/tank transfer; optimize duration (standard starting point) |
| Membrane | 0.45 µm PVDF (standard starting point) |
| Blocking | 5% milk or 5% BSA in TBST (standard starting point) |
| Primary antibody | A02144-2; use the WB datasheet starting dilution (standard starting point) |
| Primary incubation | Overnight at 4 °C (standard starting point) |
| Secondary antibody | Species-matched HRP conjugate at validated dilution (standard starting point) |
| Secondary incubation | 1 h at room temperature (standard starting point) |
| Wash | 3 × 5 min in TBST (standard starting point) |
| Detection | ECL; bracket exposures to avoid saturation (standard starting point) |
AOX1 has a predicted 147.9 kDa monomer; homodimerization could affect migration, but no empirical band size or demonstrated shift is supplied.
| Band near 148 kDa | Consistent with the predicted AOX1 monomer; confirm identity with antibody controls |
| Band near 296 kDa | Could reflect retained AOX1 homodimer |
| Band in cytoplasmic lysate | Consistent with AOX1 cytoplasmic localization |
| No visible shift after phosphatase treatment | Ser1068 phosphorylation need not cause a detectable mobility change |
| Predicted monomer mass | Places the expected monomer near 147.9 kDa |
| Sequence-derived mass | Gives the same monomer prediction as 147918 Da |
| AOX1 homodimer | Could yield a band near twice the monomer mass if the complex remains intact |
| Homodimer dissociation | Would favor monomer migration near the predicted mass |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | AOX1 may be scarce in the sampled cells | Check AOX1 expression and include a verified positive lysate |
| Band higher than expected | An AOX1 homodimer may remain intact | Compare denaturing conditions and verify the band by AOX1 depletion |
| Band lower than expected | Band identity or protein integrity is uncertain | Check molecular weight markers and test whether AOX1 depletion removes the band |
| Multiple bands | Monomer and retained homodimer are possible | Compare denaturing conditions and confirm each band with AOX1 depletion |
| Weak or no signal | AOX1 abundance or detection sensitivity may be insufficient | Verify loading and use a confirmed AOX1 positive control |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adrenal gland | glandular cells | High | Protein (IHC) | HPA → |
| Liver | hepatocytes | High | Protein (IHC) | HPA → |
| Testis | Leydig cells | High | Protein (IHC) | HPA → |
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adipose tissue | adipocytes | Not detected | Protein (IHC) | HPA → |
| Appendix | glandular cells | Not detected | Protein (IHC) | HPA → |
| Bone marrow | hematopoietic cells | Not detected | Protein (IHC) | HPA → |
| Breast | adipocytes | Not detected | Protein (IHC) | HPA → |
| Bronchus | respiratory epithelial cells | Not detected | Protein (IHC) | HPA → |
Deeper troubleshooting and optimisation questions for AOX1, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
Two the supplier anti-AOX1 antibodies are listed with WB images. A02144-2 has a caption naming MCF-7, sp2/0, and PC12 lysates at 1:500; A02144-1 reports various cells at 1:2000 without naming them. No publication evidence is supplied.
Which to pick: Choose A02144-2 for reported human, mouse, or rat reactivity and the named WB lysate examples. A02144-1 lists human and rat reactivity and has a WB image, but its caption does not identify the cells tested.